Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
Vaccine ; 11(9): 925-8, 1993.
Article in English | MEDLINE | ID: mdl-8212838

ABSTRACT

Successful field oral vaccination and protection against viral diseases have so far been achieved only with live-attenuated or live-recombinant virus vaccines. In this communication, we present data that demonstrate that a glycoprotein derived from recombinant baculovirus-infected insect cells is efficacious as an oral vaccine. The glycoprotein (G) of rabies virus (Evelyn Rokitnicki Abelseth strain) was abundantly expressed in a baculovirus expression system and oral vaccination of racoons with the baculovirus-expressed G protein resulted in the production of rabies virus-neutralizing antibodies and protection against a lethal challenge with a street rabies virus. The potential for using the baculovirus-expressed G protein for oral immunization of wildlife is discussed.


Subject(s)
Antibodies, Viral/biosynthesis , Antigens, Viral , Baculoviridae , Glycoproteins/immunology , Rabies Vaccines/administration & dosage , Rabies virus/immunology , Raccoons/immunology , Vaccination/veterinary , Vaccines, Synthetic/administration & dosage , Viral Envelope Proteins/immunology , Administration, Oral , Animals , Antibodies, Viral/immunology , Cells, Cultured , Cricetinae , Glycoproteins/administration & dosage , Kidney , Mesocricetus , Moths , Rabies/prevention & control , Rabies Vaccines/immunology , Recombinant Fusion Proteins/immunology , Vaccination/methods , Vaccines, Synthetic/immunology , Viral Envelope Proteins/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...